Association between hidradenitis suppurativa and atopic diseases: a multi-center, propensity-score-matched cohort study
Conclusion: Atopic diseases including atopic dermatitis, asthma and allergic rhinitis are associated with HS. Further investigation is needed to assess the necessity of early screening for atopic diseases in patients with HS.PMID:38169580 | PMC:PMC10758151 | DOI:10.7150/ijms.90086 (Source: International Journal of Medical Sciences)
Source: International Journal of Medical Sciences - January 3, 2024 Category: Biomedical Science Authors: Hui-Chin Chang Chen-Yu Lin Yu-Chen Guo Hsin-Yo Lu Chien-Ying Lee Meng-Che Wu Shuo-Yan Gau Source Type: research
Allergic Contact Dermatitis in Patients With Hidradenitis Suppurativa: A Retrospective Analysis
Dermatitis. 2024 Jan 3. doi: 10.1089/derm.2023.0124. Online ahead of print.NO ABSTRACTPMID:38170189 | DOI:10.1089/derm.2023.0124 (Source: Dermatitis)
Source: Dermatitis - January 3, 2024 Category: Dermatology Authors: Ning McKenzie Lauren Schaefer Jill Killian Molly Youssef Afsaneh Alavi Mark Davis Source Type: research
Association between hidradenitis suppurativa and atopic diseases: a multi-center, propensity-score-matched cohort study
Conclusion: Atopic diseases including atopic dermatitis, asthma and allergic rhinitis are associated with HS. Further investigation is needed to assess the necessity of early screening for atopic diseases in patients with HS.PMID:38169580 | PMC:PMC10758151 | DOI:10.7150/ijms.90086 (Source: International Journal of Medical Sciences)
Source: International Journal of Medical Sciences - January 3, 2024 Category: Biomedical Science Authors: Hui-Chin Chang Chen-Yu Lin Yu-Chen Guo Hsin-Yo Lu Chien-Ying Lee Meng-Che Wu Shuo-Yan Gau Source Type: research
Taiwanese Dermatological Association (TDA) consensus recommendations for the definition, classification, diagnosis, and management of hidradenitis suppurativa
J Formos Med Assoc. 2023 Dec 29:S0929-6646(23)00492-8. doi: 10.1016/j.jfma.2023.12.012. Online ahead of print.ABSTRACTHidradenitis suppurativa (HS) is a chronic inflammatory follicular disease characterized by painful, recurrent, inflamed lesions most commonly occurring in the axillary, inguinal, and anogenital regions. HS can inflict immense physical and psychological impact on patients who suffer from this distressing disease. Management of HS generally requires combining various medical and procedural treatment modalities; however, the disease is often recalcitrant to conventional treatments. In light of recent evidence...
Source: J Formos Med Assoc - December 30, 2023 Category: General Medicine Authors: Yi-Hua Liao Chia-Bao Chu Chung-Yee Rosaline Hui Cheng-Yuan Li Sheng-Yao Lin Han-Chi Tseng Yen-Jen Wang Jennifer Wu Wei-Wen Yu Sheau-Chiou Chao Source Type: research
Topical and IL therapies for hidradenitis suppurativa: A systematic literature review
CONCLUSION: The quality of evidence supporting the use of topical, or IL treatments is low. However, it supports the use of topical clindamycin, PDT, and BTX. Well-designed RCTs with standardized outcomes and homogeneous populations of patients and lesions are needed to support decision-making in the routine clinical practice.PMID:38159839 | DOI:10.1016/j.ad.2023.12.001 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - December 30, 2023 Category: Dermatology Authors: Jos é C Pascual Rub én Hernández-Quiles Ver ónica Sánchez-García Adri án Viudez-Martínez Isabel Belinch ón Francisca Sivera Source Type: research
Topical and IL therapies for hidradenitis suppurativa: A systematic literature review
CONCLUSION: The quality of evidence supporting the use of topical, or IL treatments is low. However, it supports the use of topical clindamycin, PDT, and BTX. Well-designed RCTs with standardized outcomes and homogeneous populations of patients and lesions are needed to support decision-making in the routine clinical practice.PMID:38159839 | DOI:10.1016/j.ad.2023.12.001 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - December 30, 2023 Category: Dermatology Authors: Jos é C Pascual Rub én Hernández-Quiles Ver ónica Sánchez-García Adri án Viudez-Martínez Isabel Belinch ón Francisca Sivera Source Type: research
Topical and IL therapies for hidradenitis suppurativa: A systematic literature review
CONCLUSION: The quality of evidence supporting the use of topical, or IL treatments is low. However, it supports the use of topical clindamycin, PDT, and BTX. Well-designed RCTs with standardized outcomes and homogeneous populations of patients and lesions are needed to support decision-making in the routine clinical practice.PMID:38159839 | DOI:10.1016/j.ad.2023.12.001 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - December 30, 2023 Category: Dermatology Authors: Jos é C Pascual Rub én Hernández-Quiles Ver ónica Sánchez-García Adri án Viudez-Martínez Isabel Belinch ón Francisca Sivera Source Type: research
Topical and IL therapies for hidradenitis suppurativa: A systematic literature review
CONCLUSION: The quality of evidence supporting the use of topical, or IL treatments is low. However, it supports the use of topical clindamycin, PDT, and BTX. Well-designed RCTs with standardized outcomes and homogeneous populations of patients and lesions are needed to support decision-making in the routine clinical practice.PMID:38159839 | DOI:10.1016/j.ad.2023.12.001 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - December 30, 2023 Category: Dermatology Authors: Jos é C Pascual Rub én Hernández-Quiles Ver ónica Sánchez-García Adri án Viudez-Martínez Isabel Belinch ón Francisca Sivera Source Type: research
Management of hidradenitis suppurativa tunnels using drainage setons: retrospective, multicentric study
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - December 28, 2023 Category: Dermatology Authors: Javier Fern ández-Vela, Jorge Romaní, Fernando Cabo, María Pousa, Gemma Camiña, Antonio Guilabert, Eva Vilarrasa Source Type: research
Management of hidradenitis suppurativa tunnels using drainage setons: A retrospective multicentric study
To the Editor: Hidradenitis suppurativa (HS) is an chronic skin disease characterized by inflammatory lesions and scars. The presence of tunnels poses challenges for effective treatment.1 Drainage setons, which are flexible plastic or silicone bands that are introduced into the tunnels of HS, have been used for the management of perianal fistulas. We aimed to evaluate the clinical outcomes of drainage seton placement2 in HS lesions at 3 Spanish hospitals. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - December 28, 2023 Category: Dermatology Authors: Javier Fern ández-Vela, Jorge Romaní, Fernando Cabo, María Pousa, Gemma Camiña, Antonio Guilabert, Eva Vilarrasa Tags: Research letter Source Type: research
A systematic review of Janus kinase inhibitors and spleen tyrosine kinase inhibitors for Hidradenitis suppurativa treatment
CONCLUSION: JAK and Syk inhibitors are potentially efficacious in managing moderate-to-severe HS since the proinflammatory cytokines are mediated by JAK and Syk signaling pathways. However, further research with a more rigorous examination is mandatory to evaluate such medication's long-term safety and efficacy.PMID:38150881 | DOI:10.1016/j.intimp.2023.111435 (Source: International Immunopharmacology)
Source: International Immunopharmacology - December 27, 2023 Category: Allergy & Immunology Authors: Amirhossein Heidari Yekta Ghane Nazila Heidari Sara Sadeghi Azadeh Goodarzi Source Type: research
A systematic review of Janus kinase inhibitors and spleen tyrosine kinase inhibitors for Hidradenitis suppurativa treatment
CONCLUSION: JAK and Syk inhibitors are potentially efficacious in managing moderate-to-severe HS since the proinflammatory cytokines are mediated by JAK and Syk signaling pathways. However, further research with a more rigorous examination is mandatory to evaluate such medication's long-term safety and efficacy.PMID:38150881 | DOI:10.1016/j.intimp.2023.111435 (Source: International Immunopharmacology)
Source: International Immunopharmacology - December 27, 2023 Category: Allergy & Immunology Authors: Amirhossein Heidari Yekta Ghane Nazila Heidari Sara Sadeghi Azadeh Goodarzi Source Type: research
